814 related articles for article (PubMed ID: 27291069)
1. Application of lipid nanoparticles to ocular drug delivery.
Battaglia L; Serpe L; Foglietta F; Muntoni E; Gallarate M; Del Pozo Rodriguez A; Solinis MA
Expert Opin Drug Deliv; 2016 Dec; 13(12):1743-1757. PubMed ID: 27291069
[TBL] [Abstract][Full Text] [Related]
2. Recent advance of nanoparticle-based topical drug delivery to the posterior segment of the eye.
Wang Y; Xu X; Gu Y; Cheng Y; Cao F
Expert Opin Drug Deliv; 2018 Jul; 15(7):687-701. PubMed ID: 29985660
[TBL] [Abstract][Full Text] [Related]
3. Drug delivery to the posterior segment of the eye.
Fischer N; Narayanan R; Loewenstein A; Kuppermann BD
Eur J Ophthalmol; 2011; 21 Suppl 6():S20-6. PubMed ID: 23264325
[TBL] [Abstract][Full Text] [Related]
4. Ocular Drug Delivery - New Strategies for Targeting Anterior and Posterior Segments of the Eye.
Fangueiro JF; Veiga F; Silva AM; Souto EB
Curr Pharm Des; 2016; 22(9):1135-46. PubMed ID: 26675225
[TBL] [Abstract][Full Text] [Related]
5. Lipid nanoparticles as drug/gene delivery systems to the retina.
del Pozo-Rodríguez A; Delgado D; Gascón AR; Solinís MÁ
J Ocul Pharmacol Ther; 2013 Mar; 29(2):173-88. PubMed ID: 23286300
[TBL] [Abstract][Full Text] [Related]
6. Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases.
Onugwu AL; Nwagwu CS; Onugwu OS; Echezona AC; Agbo CP; Ihim SA; Emeh P; Nnamani PO; Attama AA; Khutoryanskiy VV
J Control Release; 2023 Feb; 354():465-488. PubMed ID: 36642250
[TBL] [Abstract][Full Text] [Related]
7. Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: Pharmacokinetic studies on rabbits.
Chetoni P; Burgalassi S; Monti D; Tampucci S; Tullio V; Cuffini AM; Muntoni E; Spagnolo R; Zara GP; Cavalli R
Eur J Pharm Biopharm; 2016 Dec; 109():214-223. PubMed ID: 27789355
[TBL] [Abstract][Full Text] [Related]
8. A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases.
Choonara YE; Pillay V; Danckwerts MP; Carmichael TR; du Toit LC
J Pharm Sci; 2010 May; 99(5):2219-39. PubMed ID: 19894268
[TBL] [Abstract][Full Text] [Related]
9. Lipid nanocarriers (LNC) and their applications in ocular drug delivery.
Puglia C; Offerta A; Carbone C; Bonina F; Pignatello R; Puglisi G
Curr Med Chem; 2015; 22(13):1589-602. PubMed ID: 25666802
[TBL] [Abstract][Full Text] [Related]
10. Drug delivery to the posterior segment of the eye.
Thrimawithana TR; Young S; Bunt CR; Green C; Alany RG
Drug Discov Today; 2011 Mar; 16(5-6):270-7. PubMed ID: 21167306
[TBL] [Abstract][Full Text] [Related]
11. Applications of Nanotechnology-mediated Herbal Nanosystems for Ophthalmic Drug.
Shree D; Patra CN; Sahoo BM
Pharm Nanotechnol; 2024; 12(3):229-250. PubMed ID: 37587812
[TBL] [Abstract][Full Text] [Related]
12. Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye - Part I - Barriers and determining factors in ocular delivery.
Sánchez-López E; Espina M; Doktorovova S; Souto EB; García ML
Eur J Pharm Biopharm; 2017 Jan; 110():70-75. PubMed ID: 27789358
[TBL] [Abstract][Full Text] [Related]
13. Nano-Based Drug Delivery System: Recent Strategies for the Treatment of Ocular Disease and Future Perspective.
Qamar Z; Qizilbash FF; Iqubal MK; Ali A; Narang JK; Ali J; Baboota S
Recent Pat Drug Deliv Formul; 2019; 13(4):246-254. PubMed ID: 31884933
[TBL] [Abstract][Full Text] [Related]
14. Designing lipid nanoparticles for topical ocular drug delivery.
Alvarez-Trabado J; Diebold Y; Sanchez A
Int J Pharm; 2017 Oct; 532(1):204-217. PubMed ID: 28893582
[TBL] [Abstract][Full Text] [Related]
15. A review on recent drug delivery systems for posterior segment of eye.
Nayak K; Misra M
Biomed Pharmacother; 2018 Nov; 107():1564-1582. PubMed ID: 30257375
[TBL] [Abstract][Full Text] [Related]
16. Recent Advances in Ocular Drug Delivery, with Special Emphasis on Lipid Based Nanocarriers.
Sah AK; Suresh PK
Recent Pat Nanotechnol; 2015; 9(2):94-105. PubMed ID: 27009124
[TBL] [Abstract][Full Text] [Related]
17. Minimally invasive microneedles for ocular drug delivery.
Thakur Singh RR; Tekko I; McAvoy K; McMillan H; Jones D; Donnelly RF
Expert Opin Drug Deliv; 2017 Apr; 14(4):525-537. PubMed ID: 27485251
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticles for drug delivery to the anterior segment of the eye.
Janagam DR; Wu L; Lowe TL
Adv Drug Deliv Rev; 2017 Dec; 122():31-64. PubMed ID: 28392306
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in topical nano drug-delivery systems for the anterior ocular segment.
Lakhani P; Patil A; Majumdar S
Ther Deliv; 2018 Feb; 9(2):137-153. PubMed ID: 29325511
[TBL] [Abstract][Full Text] [Related]
20. Prodrugs and nanomicelles to overcome ocular barriers for drug penetration.
Gote V; Ansong M; Pal D
Expert Opin Drug Metab Toxicol; 2020 Oct; 16(10):885-906. PubMed ID: 32729364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
